| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |